Enzymatica AB (publ) (STO:ENZY)
2.590
+0.390 (17.73%)
Nov 4, 2026, 5:29 PM CET
Enzymatica AB Revenue
Enzymatica AB had revenue of 14.57M SEK in the quarter ending September 30, 2026, a decrease of -2.94%. This brings the company's total for the last twelve months to 51.49M, down -2.36% year-over-year. In the year 2025, Enzymatica AB had annual revenue of 53.90M with 18.27% growth. That makes Enzymatica AB the 39,827th largest company in the world by revenue and 557th in Sweden.
Revenue (ttm)
51.49M
Revenue Growth
-2.36%
P/S Ratio
10.37
Revenue / Employee
3.03M
Employees
18
Market Cap
628.68M
Revenue by Geography
- Sweden 41.56M 77.1%
- Europe 11.88M 22.0%
- Elsewhere in The World 465.00K 0.9%
Fiscal year ended Dec 31, 2025 See the full Enzymatica AB breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 53.90M | 8.33M | 18.27% |
| Dec 31, 2024 | 45.58M | -5.33M | -10.47% |
| Dec 31, 2023 | 50.90M | 1.96M | 4.00% |
| Dec 31, 2022 | 48.95M | -8.30M | -14.49% |
| Dec 31, 2021 | 57.24M | -54.00M | -48.54% |
| Dec 31, 2020 | 111.25M | 49.94M | 81.46% |
| Dec 31, 2019 | 61.31M | 8.75M | 16.64% |
| Dec 31, 2018 | 52.56M | -6.89M | -11.58% |
| Dec 31, 2017 | 59.45M | 22.96M | 62.95% |
| Dec 31, 2016 | 36.48M | 8.57M | 30.70% |
| Dec 31, 2015 | 27.91M | 8.85M | 46.42% |
| Dec 31, 2014 | 19.06M | 8.57M | 81.74% |
| Dec 31, 2013 | 10.49M | 9.59M | 1,071.96% |
| Dec 31, 2012 | 895.00K | 313.00K | 53.78% |
| Dec 31, 2011 | 582.00K | - | - |
| Apr 30, 2011 | - | - | - |
| Apr 30, 2010 | - | - | - |
| Apr 30, 2009 | - | - | - |
| Apr 30, 2008 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| EQL Pharma AB | 432.35M |
| Newbury Pharmaceuticals AB | 44.39M |
| Cinclus Pharma Holding AB | 35.18M |
| Nanexa AB | 33.86M |
| Moberg Pharma AB | 16.76M |
| Orexo AB | 12.50M |
| Enorama Pharma AB | 1.45M |
| Dicot Pharma AB | 200.00K |
Enzymatica AB News
- 6 days ago - Enzymatica AB Quarterly report: Q3 2026 - Filings
- 3 months ago - Enzymatica AB Quarterly report: Q2 2026 - Filings
- 6 months ago - Enzymatica AB Quarterly report: Q1 2026 - Filings
- 8 months ago - Enzymatica AB Annual report: Q4 2025 - Filings
- 8 months ago - Enzymatica AB Quarterly report: Q4 2025 - Filings